ResearcherWeill Cornell MedicineNo recent work listed

John Blenis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3622-2337; OpenAlex author ID A5019076582. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2021: 1 paper

Papers 1

NADK is activated by oncogenic signaling to sustain pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.celrep.2021.109238 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Tanya Schild · 1 shared paper, 2021 · strength 0.12
- Paper NADK is activated by oncogenic signaling to sustain pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2021.109238 ↗
Joshua D. Rabinowitz · 1 shared paper, 2021 · strength 0.12
- Paper NADK is activated by oncogenic signaling to sustain pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2021.109238 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.